Top Industry Leaders in the Food Allergy Diagnosis Treatment Market
Latest Food Allergy Diagnosis Treatment Companies Update
Aimmune Therapeutics Completed enrollment in pivotal Phase 3 trial for AR101 peanut oral immunotherapy in adolescents (ARRES study results expected in 2025).
Nestlé Health Science Partnered with DBV Technologies to commercialize Viaskin Peanut in the US and Canada.
Spero Foods: Received Breakthrough Device Designation from the FDA for its peanut allergy desensitizing therapeutic (AR101).
Adial Pharmaceuticals Initiated Phase 2b trial of AD-101 for milk allergy.
Neximmune Announced positive interim data from Phase 2 trial of NEXI-001 for peanut allergy.
List of Food Allergy Diagnosis Treatment Key Companies in the Market
- SGS S.A. (Switzerland)
- Microbac Laboratories, Inc. (US)
- Intertek Group PLC (UK)
- AsureQuality Limited (New Zealand)
- TÜV SÜD AG (Singapore)
- Mérieux NutriSciences Corporation (US)
- Eurofins Scientific SE (Luxembourg)
- ALS Limited (Australia)